Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Intradermal Methylene Blue Injection on the Quality of Recovery in Patients Undergoing Hemorrhoidectomy: a Multicenter Prospective Cohort Study

NCT06747195 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.

NCT NCT06747195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06747195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Intradermal Methylene Blue Injection on the Quality of Recovery in Patients Undergoing Hemorrhoidectomy: a Multicenter Prospective Cohort Study
Lead sponsor
Qilu Hospital of Shandong University
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2025
Completion date
December 31, 2026
Enrollment
290 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhoidectomy, postoperative analgesia